1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lab Automation in Proteomics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Lab Automation in Proteomics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Lab Automation in Proteomics by Country/Region, 2018, 2022 & 2029
2.2 Lab Automation in Proteomics Segment by Type
2.2.1 Automated Liquid Handlers
2.2.2 Automated Plate Handlers
2.2.3 Robotic Arms
2.2.4 Automated Storage and Retrieval Systems
2.2.5 Others
2.3 Lab Automation in Proteomics Sales by Type
2.3.1 Global Lab Automation in Proteomics Sales Market Share by Type (2018-2023)
2.3.2 Global Lab Automation in Proteomics Revenue and Market Share by Type (2018-2023)
2.3.3 Global Lab Automation in Proteomics Sale Price by Type (2018-2023)
2.4 Lab Automation in Proteomics Segment by Application
2.4.1 Hospitals and Private Labs
2.4.2 Biotech and Pharma
2.4.3 Academics and Research Institutes
2.4.4 Others
2.5 Lab Automation in Proteomics Sales by Application
2.5.1 Global Lab Automation in Proteomics Sale Market Share by Application (2018-2023)
2.5.2 Global Lab Automation in Proteomics Revenue and Market Share by Application (2018-2023)
2.5.3 Global Lab Automation in Proteomics Sale Price by Application (2018-2023)
3 Global Lab Automation in Proteomics by Company
3.1 Global Lab Automation in Proteomics Breakdown Data by Company
3.1.1 Global Lab Automation in Proteomics Annual Sales by Company (2018-2023)
3.1.2 Global Lab Automation in Proteomics Sales Market Share by Company (2018-2023)
3.2 Global Lab Automation in Proteomics Annual Revenue by Company (2018-2023)
3.2.1 Global Lab Automation in Proteomics Revenue by Company (2018-2023)
3.2.2 Global Lab Automation in Proteomics Revenue Market Share by Company (2018-2023)
3.3 Global Lab Automation in Proteomics Sale Price by Company
3.4 Key Manufacturers Lab Automation in Proteomics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lab Automation in Proteomics Product Location Distribution
3.4.2 Players Lab Automation in Proteomics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lab Automation in Proteomics by Geographic Region
4.1 World Historic Lab Automation in Proteomics Market Size by Geographic Region (2018-2023)
4.1.1 Global Lab Automation in Proteomics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Lab Automation in Proteomics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Lab Automation in Proteomics Market Size by Country/Region (2018-2023)
4.2.1 Global Lab Automation in Proteomics Annual Sales by Country/Region (2018-2023)
4.2.2 Global Lab Automation in Proteomics Annual Revenue by Country/Region (2018-2023)
4.3 Americas Lab Automation in Proteomics Sales Growth
4.4 APAC Lab Automation in Proteomics Sales Growth
4.5 Europe Lab Automation in Proteomics Sales Growth
4.6 Middle East & Africa Lab Automation in Proteomics Sales Growth
5 Americas
5.1 Americas Lab Automation in Proteomics Sales by Country
5.1.1 Americas Lab Automation in Proteomics Sales by Country (2018-2023)
5.1.2 Americas Lab Automation in Proteomics Revenue by Country (2018-2023)
5.2 Americas Lab Automation in Proteomics Sales by Type
5.3 Americas Lab Automation in Proteomics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lab Automation in Proteomics Sales by Region
6.1.1 APAC Lab Automation in Proteomics Sales by Region (2018-2023)
6.1.2 APAC Lab Automation in Proteomics Revenue by Region (2018-2023)
6.2 APAC Lab Automation in Proteomics Sales by Type
6.3 APAC Lab Automation in Proteomics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lab Automation in Proteomics by Country
7.1.1 Europe Lab Automation in Proteomics Sales by Country (2018-2023)
7.1.2 Europe Lab Automation in Proteomics Revenue by Country (2018-2023)
7.2 Europe Lab Automation in Proteomics Sales by Type
7.3 Europe Lab Automation in Proteomics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lab Automation in Proteomics by Country
8.1.1 Middle East & Africa Lab Automation in Proteomics Sales by Country (2018-2023)
8.1.2 Middle East & Africa Lab Automation in Proteomics Revenue by Country (2018-2023)
8.2 Middle East & Africa Lab Automation in Proteomics Sales by Type
8.3 Middle East & Africa Lab Automation in Proteomics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lab Automation in Proteomics
10.3 Manufacturing Process Analysis of Lab Automation in Proteomics
10.4 Industry Chain Structure of Lab Automation in Proteomics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lab Automation in Proteomics Distributors
11.3 Lab Automation in Proteomics Customer
12 World Forecast Review for Lab Automation in Proteomics by Geographic Region
12.1 Global Lab Automation in Proteomics Market Size Forecast by Region
12.1.1 Global Lab Automation in Proteomics Forecast by Region (2024-2029)
12.1.2 Global Lab Automation in Proteomics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lab Automation in Proteomics Forecast by Type
12.7 Global Lab Automation in Proteomics Forecast by Application
13 Key Players Analysis
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Information
13.1.2 Thermo Fisher Scientific Lab Automation in Proteomics Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Thermo Fisher Scientific Main Business Overview
13.1.5 Thermo Fisher Scientific Latest Developments
13.2 Danaher
13.2.1 Danaher Company Information
13.2.2 Danaher Lab Automation in Proteomics Product Portfolios and Specifications
13.2.3 Danaher Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Danaher Main Business Overview
13.2.5 Danaher Latest Developments
13.3 Hudson Robotics
13.3.1 Hudson Robotics Company Information
13.3.2 Hudson Robotics Lab Automation in Proteomics Product Portfolios and Specifications
13.3.3 Hudson Robotics Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hudson Robotics Main Business Overview
13.3.5 Hudson Robotics Latest Developments
13.4 Becton, Dickinson and Company
13.4.1 Becton, Dickinson and Company Company Information
13.4.2 Becton, Dickinson and Company Lab Automation in Proteomics Product Portfolios and Specifications
13.4.3 Becton, Dickinson and Company Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Becton, Dickinson and Company Main Business Overview
13.4.5 Becton, Dickinson and Company Latest Developments
13.5 Synchron Lab Automation
13.5.1 Synchron Lab Automation Company Information
13.5.2 Synchron Lab Automation Lab Automation in Proteomics Product Portfolios and Specifications
13.5.3 Synchron Lab Automation Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Synchron Lab Automation Main Business Overview
13.5.5 Synchron Lab Automation Latest Developments
13.6 Agilent Technologies
13.6.1 Agilent Technologies Company Information
13.6.2 Agilent Technologies Lab Automation in Proteomics Product Portfolios and Specifications
13.6.3 Agilent Technologies Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Agilent Technologies Main Business Overview
13.6.5 Agilent Technologies Latest Developments
13.7 Siemens Healthineers
13.7.1 Siemens Healthineers Company Information
13.7.2 Siemens Healthineers Lab Automation in Proteomics Product Portfolios and Specifications
13.7.3 Siemens Healthineers Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Siemens Healthineers Main Business Overview
13.7.5 Siemens Healthineers Latest Developments
13.8 Tecan Group Ltd
13.8.1 Tecan Group Ltd Company Information
13.8.2 Tecan Group Ltd Lab Automation in Proteomics Product Portfolios and Specifications
13.8.3 Tecan Group Ltd Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Tecan Group Ltd Main Business Overview
13.8.5 Tecan Group Ltd Latest Developments
13.9 PerkinElmer
13.9.1 PerkinElmer Company Information
13.9.2 PerkinElmer Lab Automation in Proteomics Product Portfolios and Specifications
13.9.3 PerkinElmer Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 PerkinElmer Main Business Overview
13.9.5 PerkinElmer Latest Developments
13.10 Bio-Rad
13.10.1 Bio-Rad Company Information
13.10.2 Bio-Rad Lab Automation in Proteomics Product Portfolios and Specifications
13.10.3 Bio-Rad Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Bio-Rad Main Business Overview
13.10.5 Bio-Rad Latest Developments
13.11 Roche
13.11.1 Roche Company Information
13.11.2 Roche Lab Automation in Proteomics Product Portfolios and Specifications
13.11.3 Roche Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Roche Main Business Overview
13.11.5 Roche Latest Developments
13.12 Shimadzu Corporation
13.12.1 Shimadzu Corporation Company Information
13.12.2 Shimadzu Corporation Lab Automation in Proteomics Product Portfolios and Specifications
13.12.3 Shimadzu Corporation Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Shimadzu Corporation Main Business Overview
13.12.5 Shimadzu Corporation Latest Developments
13.13 Aurora Biomed
13.13.1 Aurora Biomed Company Information
13.13.2 Aurora Biomed Lab Automation in Proteomics Product Portfolios and Specifications
13.13.3 Aurora Biomed Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Aurora Biomed Main Business Overview
13.13.5 Aurora Biomed Latest Developments
13.14 GENEWIZ
13.14.1 GENEWIZ Company Information
13.14.2 GENEWIZ Lab Automation in Proteomics Product Portfolios and Specifications
13.14.3 GENEWIZ Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 GENEWIZ Main Business Overview
13.14.5 GENEWIZ Latest Developments
13.15 Illumina
13.15.1 Illumina Company Information
13.15.2 Illumina Lab Automation in Proteomics Product Portfolios and Specifications
13.15.3 Illumina Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Illumina Main Business Overview
13.15.5 Illumina Latest Developments
13.16 Bruker Corporation
13.16.1 Bruker Corporation Company Information
13.16.2 Bruker Corporation Lab Automation in Proteomics Product Portfolios and Specifications
13.16.3 Bruker Corporation Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Bruker Corporation Main Business Overview
13.16.5 Bruker Corporation Latest Developments
13.17 GE Healthcare
13.17.1 GE Healthcare Company Information
13.17.2 GE Healthcare Lab Automation in Proteomics Product Portfolios and Specifications
13.17.3 GE Healthcare Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 GE Healthcare Main Business Overview
13.17.5 GE Healthcare Latest Developments
13.18 Luminex Corporation
13.18.1 Luminex Corporation Company Information
13.18.2 Luminex Corporation Lab Automation in Proteomics Product Portfolios and Specifications
13.18.3 Luminex Corporation Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Luminex Corporation Main Business Overview
13.18.5 Luminex Corporation Latest Developments
13.19 Waters Corporation
13.19.1 Waters Corporation Company Information
13.19.2 Waters Corporation Lab Automation in Proteomics Product Portfolios and Specifications
13.19.3 Waters Corporation Lab Automation in Proteomics Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Waters Corporation Main Business Overview
13.19.5 Waters Corporation Latest Developments
14 Research Findings and Conclusion
※参考情報 プロテオミクスは、全体のタンパク質の発現、構造、機能を体系的に研究する分野であり、生命科学において重要な役割を果たしています。このような研究の進展において、ラボ自動化技術は欠かせない要素となっています。研究室の自動化は、プロテオミクス研究における高効率化、再現性の確保、データの信頼性向上などに寄与しています。 まず、研究室自動化の基本的な概念を考えると、それは実験手法やプロセスを自動で行うことができる技術やシステムのことを指します。これにより、時間の節約、人的エラーの軽減、複雑な実験プロセスの簡略化が実現されます。特にプロテオミクスにおいては、サンプルの調製から分析、データ取得までの多岐にわたる工程があるため、自動化の導入は不可欠です。 自動化の特徴としては、まずそのスピードが挙げられます。従来の手作業に比べて、試料の処理速度が飛躍的に向上します。また、反復性も高く、同一条件下での再実験が容易になります。これにより、実験結果の信頼性が増し、科学的発見の精度が向上します。また、実験室の自動化は、多くの場合、複数のプロセスを同時に行えるため、効率的なリソースの使用が可能となります。 プロテオミクスにおける自動化の種類には、いくつかの異なる技術が含まれます。例えば、ロボティックアームや全自動サンプル前処理機、液体ハンドリングシステムが一般的です。これらの機器は、弁当のように配置された試料から正確に試薬を分注し、培養や反応を行うことができます。また、高速液体クロマトグラフィー(HPLC)や質量分析計(MS)などの分析機器も自動化が進んでおり、サンプルの分析速度が向上しています。 用途としては、第一に、タンパク質の同定や定量に関する研究が挙げられます。自動化されたプロテオミクスは、多数のサンプルを迅速に処理し、データを収集できます。これにより、疾患のバイオマーカーの探索、薬剤の作用メカニズムの理解、さらには個別化医療への応用も期待されています。また、統合的なプロテオミクス研究においては、代謝物や遺伝子発現データと統合するための自動化も重要です。 関連技術としては、ビッグデータ解析や機械学習の手法が挙げられます。自動化によって得られた膨大なデータは、そのままでは扱いきれないため、これらの技術を用いた解析が重要です。機械学習を用いることで、プロテオミクスデータからパターンを見出し、隠れた関係性を抽出することが可能になります。また、これによりデータの解釈が容易になり、新たな知見を得るための重要なツールとなります。 さらに、クラウド技術や分散コンピューティングの活用も進んでおり、分散したデータを効率的に際立たせるためのシステムが構築されています。これにより、研究者は場所にとらわれずに協力し、多様な視点から問題解決が行える環境が整います。 プロテオミクスにおける研究室自動化は、実験の精度を高めるだけでなく、データ解析の新しい可能性を切り開くことに貢献しています。今後、ますます高度化する技術によって、より複雑な生物学的問題へのアプローチが可能になることが期待されます。自動化は、研究の生産性を向上させるだけでなく、研究者が創造的な思考を発揮しやすくする環境を整える役割も果たしています。 このように、プロテオミクスにおける研究室自動化は非常に多面的であり、技術的な進歩が実験の質やスピードを向上させるだけでなく、新たな科学的発見を促進する重要な要素であることが理解されます。将来的には、これら新しい技術がさらに進化し、より深い生物学的理解をもたらすことが期待されます。自動化技術の発展は、プロテオミクスの未来を形作る重要な要素として、研究者たちにとって極めて重要なテーマであり続けるでしょう。 |